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Abstract
Exposure to tobacco smoke is the number one risk factor for lung cancer. Although the DNA
damaging properties of tobacco smoke have been well documented, relatively few studies
have examined its effect on DNA repair pathways. This is especially true for the nucleotide
excision repair (NER) pathway which recognizes and removes many structurally diverse
DNA lesions, including those introduced by chemical carcinogens present in tobacco
smoke. The aim of the present study was to investigate the effect of tobacco smoke on NER
in human lung cells. We studied the effect of cigarette smoke condensate (CSC), a surro-
gate for tobacco smoke, on the NER pathway in two different human lung cell lines; IMR-90
lung fibroblasts and BEAS-2B bronchial epithelial cells. To measure NER, we employed a
slot-blot assay to quantify the introduction and removal of UV light-induced 6–4 photoprod-
ucts and cyclobutane pyrimidine dimers. We find a dose-dependent inhibition of 6–4 photo-
product repair in both cell lines treated with CSC. Additionally, the impact of CSC on the
abundance of various NER proteins and their respective RNAs was investigated. The abun-
dance of XPC protein, which is required for functional NER, is significantly reduced by treat-
ment with CSC while the abundance of XPA protein, also required for NER, is unaffected.
Both XPC and XPA RNA levels are modestly reduced by CSC treatment. Finally, treatment
of cells with MG-132 abrogates the reduction in the abundance of XPC protein produced by
treatment with CSC, suggesting that CSC enhances proteasome-dependent turnover of the
protein that is mediated by ubiquitination. Together, these findings indicate that tobacco
smoke can inhibit the same DNA repair pathway that is also essential for the removal of
some of the carcinogenic DNA damage introduced by smoke itself, increasing the DNA
damage burden of cells exposed to tobacco smoke.
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Introduction
Lung cancer is a deadly disease and a leading cause of cancer-related mortality in the US and in
the world [1–3]. In 2012, the most recent year data is available, lung cancer accounted for 1.8
million cases of cancer and 1.6 million deaths worldwide [4, 5]. Exposure to tobacco smoke is
the predominant risk factor for the development of lung cancer and it is estimated to account
for 85–90% of all lung cancer cases [6, 7]. It is also associated with the formation of tumors at
additional sites in the body that are not directly exposed to smoke including the bladder, pan-
creas, liver, stomach and bone marrow [8, 9]. Tobacco use remains prevalent in certain regions
of the world [10] and while its use has declined in the US, approximately 50% of newly diag-
nosed lung cancers occur in former smokers [6]. Hence, lung cancer and other forms of cancer
associated with tobacco smoke exposure remain a tremendous health burden in the US and
world-wide. Continued elucidation of the molecular mechanisms that lead to the formation of
cancers associated with tobacco smoke is essential for prevention, treatment and identification
of individuals who are at greatest risk for the development of cancer.
Thousands of compounds have been identified in the vapor and particulate phases of ciga-
rette smoke and they include carcinogens, co-carcinogens, mutagens and tumor promoters.
Approximately 70 of these compounds have been classified as carcinogens [7, 11]. Different
classes of chemical carcinogens are present in tobacco smoke including the polycyclic aromatic
hydrocarbons (PAHs) such as benzo[a]pyrene (B[a]P), dibenz[a,h]anthracene and dibenzo[a,l]
pyrene. The DNA-reactive metabolites of PAHs are considered to be among the primary
tobacco smoke carcinogens [7, 12]. Metabolic activation of these and other chemical com-
pounds found in tobacco smoke can generate intermediates that react with DNA bases and
produce DNA adducts. Hence, DNA adducts are likely continually formed in the lung tissues
of people who smoke, and if they are not removed by DNA repair processes, their persistence
could lead to the formation of mutations. Many different types of genetic alterations are found
in lung cancer and they include point mutations, genomic rearrangements, amplifications and
large scale insertions and deletions. Mutations in KRAS and TP53 are frequently found in lung
tumors and lung tissues of smokers [6, 13, 14], and the accumulation of mutations in these and
other important oncogenes and tumor suppressor genes are driving forces in the development
of lung cancer.
PAH-induced DNA damage is removed by the nucleotide excision repair (NER) pathway
[15–21] and hence, NER activity is likely critical to the prevention of carcinogen-induced
mutations that contribute to neoplasia associated with smoke exposure. NER is a versatile path-
way that removes a wide variety of structurally diverse DNA lesions including those generated
by metabolites of chemical carcinogens as well as those generated by exposure to ultraviolet
(UV) light. The cylobutane pyrimidine dimer (CPD) and 6–4 photoproduct (6–4 PP), pro-
duced by UV light, are model substrates commonly studied when measuring NER activity as
they are rapidly generated by a brief exposure to UV light [22]. In mammals, at least 20 differ-
ent protein factors participate in NER, including the XPA-G factors that are singly defective in
the 7 corresponding complementation groups of the human disease, xeroderma pigmentosum
(XP). The tumor suppressor factor p53 also impacts NER efficiency probably by transcriptional
regulation of the XPC and DDB2 gene products [23–26]. The NER pathway is comprised of
two sub-pathways that differ in their mechanism of damage recognition: global genomic NER
(GG-NER) which can remove damage from anywhere in the genome and transcription-cou-
pled NER (TC-NER) which selectively removes damage from the transcribed strands of
expressed genes. In GG-NER, DNA damage recognition is accomplished by XPC, which is sta-
bilized by its binding partners RAD23B, and CENTRIN2 [27]. In TC-NER, damage is recog-
nized by the stalling of the RNA polymerase complex at the site of damage (reviewed in [28]).
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After DNA damage recognition, many of the subsequent steps are the same for GG-NER and
TC-NER. The helicase activities of TFIIH produce additional unwinding of DNA where upon
the endonuclease activities of the XPF/ERCC1 complex and XPG produce single-strand inci-
sions flanking the damaged site. The original integrity of the DNA is restored after an approxi-
mately 30 nucleotide region of DNA containing the lesion is removed, and the gap is filled by
pol δ or pol ε, using the undamaged strand as a template (reviewed in [22]).
Several different types of animal models have been used to investigate the molecular mecha-
nisms of lung cancer development caused by exposure to tobacco smoke. Unfortunately, many
smoke inhalation studies have had limited success [29–31]. The A/J mouse model has been
used extensively but it is confounded by the spontaneous lung tumors in control animals, need
for long smoke exposure and recovery regimens, low tumor induction by smoke inhalation
and responses that do not adequately mimic those found in humans exposed to tobacco smoke
[29, 32]. Greater tumor incidence has been achieved by exposing female B6C3F1 mice to life-
time, whole-body mainstream tobacco smoke [31, 33]. The utilization of mice with targeted
disruptions in tumor suppressor genes or oncogenes associated with lung cancer development
in humans may yield improved animal models and additional mechanistic insights [34].
As animal models for tobacco smoke exposure have had limited success, cigarette smoke
condensate (CSC) has been used as a surrogate for cigarette smoke exposure to study its effects
in model cell culture systems [8]. It is the particulate phase of cigarette smoke collected on
Cambridge filters and resuspended in DMSO. It is mutagenic and genotoxic and produces sev-
eral different types of mutations including point mutations, deletions, loss of heterozygosity
(LOH), microsatellite instability, sister chromatid exchanges and micronuclei [35–40]. It intro-
duces DNA damage [40–43]. It also induces human and mammalian cell transformation [44–
46] and tumor formation when applied to mouse skin [47–49]. While it is well established that
cigarette smoke introduces a variety of different types of DNA damage, it is less clear how
smoke exposure influences DNA repair efficiency and DNA damage response pathways.
Loss of DNA repair capability results in increased mutagenesis and carcinogenesis. In
mouse models, deficiencies in NER have been associated with tumorigenesis at many organ
sites including the lung [50]. Compared to normal mice, NER-deficient mice have a higher
incidence of lung tumors when exposed to B[a]P [51, 52] and XPC-deficient mice have elevated
levels of spontaneous lung tumors [53]. By extension, even a partial loss of NER efficiency in
people is likely to increase mutagenesis and cancer incidence, particularly in cases of chronic
DNA damage induction, as occurs in the lung tissue of smokers.
We have studied the effects of CSC on the NER pathway using an immuno-slot blot assay to
measure NER in two human lung cell lines; IMR-90 and BEAS-2B. We find a dose-dependent
inhibition of the efficiency of NER when both cell lines are treated with increasing concentra-
tions of CSC. Our results provide evidence for the first time that CSC can directly interfere
with the normal NER process, both in terms of overall efficiency as well as at the protein and




The human primary lung fibroblast cell line IMR-90 (obtained from the American Type Cul-
ture Collection) was grown in minimal essential medium (Eagle) containing Earle’s salts (Med-
iatech) supplemented with 0.1 mM non-essential amino acids (Lonza), 2 mM glutamine
(Mediatech), 100 units/ml penicillin, 100 μg/ml streptomycin and 10% fetal bovine serum
(Sigma). The human bronchial epithelial cell line, BEAS-2B (American Type Culture
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Collection), was grown in Dulbecco’s Modified Eagle’s Medium supplemented with 2 mM glu-
tamine, 100 units/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal bovine
serum. Both cell lines were maintained in a 5% CO2 incubator at 37°C.
Preparation of CSC
CSC was prepared using the University of Kentucky Reference 3R4F Cigarettes as previously
described [38]. Briefly, the particulate phase of smoke was collected on Cambridge filters using
a 30-port smoking machine (Borgwaldt) under standard Federal Trade Commission condi-
tions, [54] dissolved in DMSO at a concentration of 40 μg/ul, and stored in small aliquots at
-80°C. At the time of use, aliquots were thawed in a 37°C water bath and discarded after use.
Treatment of Cells with CSC
IMR-90 cells were grown to confluency prior to treatment and then treated with CSC for 24 h
unless otherwise stated. BEAS-2B cells were seeded at a density of 1.2 million cells per 10 cm
plate, allowed to grow for 24 h and log phase cells were then treated with CSC for 16 h. The
growth of BEAS-2B cells does not exhibit contact inhibition so studies could not be performed
using confluent cultures. For both cell lines, control (mock treated) cells were treated with
DMSO, the solvent used for the preparation of CSC, at a volume equal to that used for the
highest dose of CSC in each experiment.
Treatment with MG-132
MG-132, a potent inhibitor of proteasome mediated proteolysis, was prepared from a 2mM
stock solution from EMD Bioscience (catalog # 475791) stored at -20°C. The solution was
thawed immediately prior to treatment and diluted for use. To investigate how changes in the
abundance of XPC protein are influenced by UV-C irradiation, confluent IMR-90 cells were
treated with MG-132 for 4 h prior to irradiation. The cells were irradiated with 20 J/m2 UV-C
and either lysed immediately or returned to medium containing MG-132 for incubation after
UV. XPC levels were examined using the Western method described above. To investigate a
potential involvement of the proteasome in the turnover of XPC after cells are treated with
CSC, confluent IMR-90 cells were treated with 120 μg/ml CSC for 16 h in the presence or
absence of MG-132. After treatment, cells were counted and lysed, and XPC levels were mea-
sured by Western Blotting.
Analysis of Cell Viability
IMR-90 and BEAS-2B cells were grown and treated with CSC as described above. Cells were
trypsinized, washed with chilled PBS, centrifuged, and resuspended in 10 mL of chilled PBS.
Cells were counted in triplicate for each dose using trypan blue dye exclusion. For both cell
lines, the results presented are an average of four independent biological experiments unless
otherwise noted.
Measurement of Nucleotide Excision Repair
The removal of 6-4PPs and CPDs from total genomic DNA was measured using an immuno-
blot assay as previously described [55, 56] with some modifications. Cells were grown and
treated with CSC as described above. They were then washed twice with PBS and irradiated
with UV-C light to introduce photolesions; 20 J/m2 UV-C to measure the removal of 6–4 PPs
and 2 J/m2 UV-C to measure the removal of CPDs. After irradiation, cells were either lysed
immediately or after incubation in medium containing DMSO or CSC for increasing periods
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
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of time to permit repair. DNA was isolated using a Promega wizard genomic DNA isolation
kit. DNA concentration was measured using a fluorometer and H-dye. The DNA was then
denatured and equal amounts from each sample were loaded onto a Hybond nitrocellulose
membrane (Biorad) using a slot blot apparatus (100 ng of DNA per slot for the detection of
6–4 PPs and 20 ng of DNA per slot for detection of CPDs). The membrane was baked in a vac-
uum oven at 80°C for 1 h, treated with 5% nonfat dry milk (Blotto, Santa Cruz Biotechnology)
in TBST (10 mM Tris pH 8.0, 150 mMNaCl and 0.1% Tween-20) for 1 h, and incubated over-
night at 4° with mouse monoclonal antibodies (1:10,000 dilution) specific for either 6–4 PPs or
CPDs (CAC-NM-DND-002, CAC-NM-DND-001, Cosmo Bio USA) in 1% dry milk and
TBST. The following day, the membrane was washed extensively with TBST and then incu-
bated with goat anti-mouse horseradish peroxide-conjugated secondary antibodies (1:10,000
dilution, Thermo Scientific) in 1% dry milk and TBST for 2 h at room temperature. After wash-
ing, chemiluminescence (ECL–Plus, GE Healthcare Bio-Sciences Corp) and fluorimaging were
used to detect the photolesions. Image Quant computer software was employed to quantify the
signal detected by the phosphorimager. The percent repair at each time point was calculated by
dividing the signal strength of the slot-blot band obtained at each repair time point by the sig-
nal strength of the band obtained at the zero time point. For most membranes, a DNA ladder
of irradiated DNA was used as an internal control for uniformity of slotting, antibody incuba-
tion and development with chemiluminescence. Unirradiated samples of DNA were also
loaded to detect any nonspecific binding of the antibodies to DNA which in general was found
to be insignificant.
Western Analysis
The effect of CSC treatment on the abundance of XPC, XPA, and β-actin proteins in IMR-90
cells and BEAS-2B cells was determined byWestern blotting using mouse monoclonal antibod-
ies (XPA: sc-56813, XPC: sc-74411, Santa Cruz Biotechnology; β-actin: A3854, Sigma). IMR-
90 and BEAS-2B cells were treated with different concentrations of CSC or mock treated as
described above. After treatment, cells were washed with PBS and trypsinized. Approximately
five million cells were collected by centrifugation for each treatment, washed with PBS and
stored at -20° or -80°C. Each sample of frozen cells was thawed on ice, resuspended in 200 μl
RIPA buffer (50 mM Tris (7.4), 150 mM NaCl, 1% NP-40, 1 mM EDTA, 0.25% Na-Deoxycho-
late) containing 0.6 mM PMSF, 1% Protease Cocktail Inhibitor (Sigma) and 2 units of DNase 1
(New England BioLabs), lysed by sonication, centrifuged at 13,500 G to remove debris, and the
amount of protein in each of the supernatants was quantified using the Bradford method.
Alternatively, cells were counted, pelleted, directly lysed in loading dye and samples were
loaded based on cell number. Samples containing 100 μg of protein were mixed with loading
dye, boiled at 100°C for 5 min, resolved in 8% (XPC/Actin) or 12% (XPA/Actin) SDS-PAGE
gels and transferred to a PVDF membrane (Bio-Rad). The membranes were incubated for one
h with 5% nonfat dry milk in TBST for blocking. For XPC and actin, the upper half of the
membrane was probed with a 1:1,000 dilution of XPC antibody and the lower half with
1:100,000 dilution of ß Actin antibody and incubated overnight at 4° C. The membrane was
then washed extensively with TBST and incubated for 2 h with 1:5,000 diluted HRP-conjugated
goat anti-mouse antibodies (GE Healthcare Bio-Sciences Corp) at room temperature. After
extensive washing with TBST, the binding of antibodies was detected using enhanced chemilu-
minescence (ECL–Plus, GE Healthcare Bio-Sciences Corp) and fluorimaging. For XPA and
actin, the full membrane was probed with 1:1,000 dilution of XPA antibody overnight at 4° C.
Washing and development for XPA was performed in the same manner as XPC. The mem-
brane was then stripped using a stripping buffer (Pierce) at 37° C for 15 min, washed with
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
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TBST, blocked and probed with actin antibody. The amount of XPC or XPA in each lane was
normalized to the amount of actin in the same lane.
Real-Time PCR
The effect of CSC on the expression of XPC, XPA, and GAPDH RNA in IMR-90 cells was mea-
sured using Real-Time PCR. Confluent cells were incubated with CSC or DMSO as a control (as
described), washed with PBS, trypsinized, centrifuged, washed with PBS and pelleted. Total RNA
was isolated from one million cells for each treatment using a GenElute mammalian total RNA
Miniprep kit (Sigma). The RNA 6000 Nano Chip kit from Agilent was used to determine the qual-
ity and concentration of RNA isolated from the cells. For each treatment, 1.5 μg of RNA was
reverse transcribed to cDNA using random primers and a high capacity cDNA RT kit (Applied
Biosystems). Primer sets specific to each gene were identified using Universal Probe Library
(Roche, http://www.universalprobelibrary.com) and synthesized by Integrated DNA Technologies.
Sequences of the primers are given in S1 Table. Reactions were carried out on a Roche LightCycler
480 system using a 96-well plate format. Each reaction (20 μl) contained 1XMaster Mix, 100 nM
fluorescent reporter probe, 200 nM of each forward and reverse primer and 5 μl of cDNA (diluted
1:10). Samples were first incubated for 10 min at 95°C followed by 40 cycles of amplification (95° C
for 15 s denaturation and 60° C for 1 min annealing). An equal volume of 1:10 diluted cDNA from
each treatment was mixed together to create the DNA used as standards. Serial dilutions of mixed
cDNA (1:1, 1:10, 1:100, 1:1,000, and 1:10,000) were used to create a standard curve. The expression
levels of RNA in the treated cells were determined by comparing their crossing point (CP) values
with the CP values of standard curves for the corresponding gene or RNA. The crossing point is
the point at which the fluorescence of a sample achieves a threshold fluorescence. The amounts of
XPC or XPA RNAwere normalized to the amounts of GAPDH RNA for each treatment.
Statistical Considerations
All statistical evaluations were done using Graph Pad Prism 6. For the experiments comparing
multiple treatments to a control, a 1-way ANOVA with a Holm-Sidak test for multiple-com-
parison was employed. For the experiments comparing one treatment to a control, a Student’s
T-test was employed. For all analyses, p<0.05 was used as the threshold for significance. Statis-
tical significance is described in the results section and not presented on the images as some
graphs contained too many significant treatments to indicate on the graphs.
Results
CSC inhibits NER in IMR-90 cells
We first investigated the effects of CSC on the NER pathway by studying a human lung fibro-
blast cell line, IMR-90. The effect of CSC on cell viability was evaluated by treating cells with a
range of different doses, 0 to 200 μg/ml, for 24 h. No significant effect on viability was observed
even after treatment of cells with 200 μg/ml, the highest concentration of CSC used (Fig 1A).
NER was studied using an immuno-slot blot assay that measures the removal of 6-4PPs or
CPDs introduced by UV irradiation. These lesions are repaired exclusively by NER in human
cells and 6-4PPs are model substrates to measure NER efficiency in total genomic DNA. In
untreated cells, 6-4PPs are rapidly removed from DNA with the majority of lesions removed
within 3 h after UV irradiation. Treatment with CSC inhibits the removal of 6-4PP lesions in a
dose-dependent fashion and the inhibition was statistically significant for all doses of CSC used
(except 60 μg/ml) at one or more time points (Fig 1B and 1C). In general, NER in CSC treated
samples was slowed but reached completion within 24 h after UV irradiation except when cells
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
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were treated with the highest dose of CSC, where both the kinetics and extent of repair were
reduced. In contrast to the rapid removal of 6-4PPs from genomic DNA found in untreated
IMR-90 cells, the removal of CPDs in untreated cells was much slower. This observation of
slow and inefficient removal of CPDs is similar to what other investigators have previously
found in human cell lines using comparable doses of UV light [57, 58]. Treatment with CSC
had only a minor inhibitory effect on the removal of CPDs (Fig 1D and 1E), with a statistically
significant difference only observed at the 48 h time point (p = .0435). It is unlikely that this
difference is biologically significant and interpretation of the values representing the amount of
repair at the 48 h time point could be confounded by replicative DNA synthesis that occurred
during the repair period. While the IMR-90 cells were studied in a confluent state, small differ-
ences in the amount of DNA replication at the 48 h time point could contribute to the differ-
ences in repair measured in the CSC-untreated and treated samples.
CSC reduces the abundance of XPC but not XPA protein in IMR-90 cells
The effect of CSC on the abundance of XPC and XPA protein was determined by western blot-
ting using whole cell lysates of IMR-90 cells treated with 120, 160 and 200 μg/ml of CSC for 24
h. These are the same doses and treatment time used to study the effects of CSC on NER.
Whole cell lysates from mock treated cells (DMSO) were used as controls. The abundance of
XPC protein was reduced in IMR-90 cells treated with increasing concentration of CSC for 24
h (Fig 2A and 2B); XPC protein levels were reduced by 56% in cells treated with 200 μg/ml of
CSC. The reduction in XPC protein compared to the mock treated cells was statistically signifi-
cant in all treatments. In contrast, there was not any statistically significant change in the abun-
dance of XPA protein in cells treated with CSC (Fig 2C and 2D). The amounts of XPC and
XPA proteins were normalized to the amounts of β actin present in each lane.
A timecourse of CSC treatment shows a correlation between the
reduction of XPC protein and the inhibition of NER
Treatment of IMR-90 cells with CSC for 24 h inhibits NER and results in reduced expression
of XPC protein. To measure the kinetics of these inhibitions, cells were treated with 200 μg/ml
of CSC and the abundance of XPC protein was measured at 4 h intervals over a 24 h period
and NER was measured after treatment with CSC for 8 h intervals over a 24 h period. A reduc-
tion in XPC protein compared to untreated cells was observed as early as 8 h and it was maxi-
mally inhibited by 16 h. The inhibition was statistically significant for all timepoints except 4 h
(Fig 3A and 3B). Significant inhibition of NER was observed at all treatment times beginning
Fig 1. CSC inhibits NER in IMR-90 human lung fibroblasts. (A) Cell viability after CSC treatment. Confluent IMR-
90 cells were treated with CSC (or mock treated with DMSO) with the concentrations shown for 24 h and the
percentage of viable cells was measured using Trypan blue dye exclusion. The data represent the mean ± SE
(Standard Error) from four independent experiments (except for 60 μg/ml CSC which included two independent
experiments). (B) Removal of 6–4 PPs. Cells were treated with the concentrations of CSC shown or with DMSO for
24 h and irradiated with 20 J/m2 UVC to introduce photolesions. After irradiation, cells were either lysed immediately
or after incubation in medium containing CSC or DMSO for the times (h) shown to permit repair. The immunoblot
assay to detect 6–4 PPs was performed and samples were loaded in duplicate for each repair time point. (C)
Removal of 6–4 PPs. A graphical representation of results obtained frommultiple immunoblots measuring the
removal of 6–4 PPs is shown. Each data point represents the mean ± SE of three repeats from two independent
experiments. (D) Removal of CPDs. IMR-90 cells were treated with 200 μg/mL CSC or with DMSO for 24 h and
irradiated with 2 J/m2 UVC to introduce photolesions. After irradiation, cells were either lysed immediately or after
incubation in medium containing CSC or DMSO for the times shown to permit repair. An immunoblot assay to detect
CPD lesions was performed and samples were loaded in triplicate for each time point. (E) Removal of CPDs. A
graphical representation of results obtained frommultiple immunoblots measuring the removal of CPDs is shown.
Each data point represents the mean ± SE of three repeats from two independent experiments.
doi:10.1371/journal.pone.0158858.g001
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Fig 2. CSC reduces the abundance of XPC, but not XPA, protein in IMR-90 cells. (A) Cells were treated
with different concentrations of CSC as shown for 24 h, and the abundance of XPC was examined by western
blot analysis. (B) A graphical representation of multiple western blots for XPC expression is shown. The data
presented are the mean ± SE from two repeats each of three independent experiments, and XPC expression
was normalized to β-actin. (C) Cells were treated as shown for 24 h, and the abundance of XPA was
measured by western blot analysis. (D) A graphical representation of multiple western blots for XPA
expression is shown. The data presented are the mean ± SE of three repeats from three independent
experiments, and XPA expression was normalized to β-actin.
doi:10.1371/journal.pone.0158858.g002
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Fig 3. The impact of CSC on XPC protein and NER efficiency depends on treatment duration. (A) IMR-
90 Cells were treated with 200 μg/ml of CSC for the times indicated and XPC expression was examined by
western blot analysis. (B) A graphical representation of multiple western blots examining the time course of
inhibition for XPC expression after CSC treatment is shown. The data presented are the mean ± SE of three
repeats from one experiment, and XPC expression was normalized to β-actin. (C) Results of an immunoblot
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
PLOS ONE | DOI:10.1371/journal.pone.0158858 July 8, 2016 10 / 22
with the 8 h treatment (Fig 3C and 3D). NER was maximally inhibited with the longest length
of treatment, 24 h, and a statistically significant difference from cells not treated with CSC was
observed for all repair timepoints.
CSCmodestly reduces XPC and XPA RNA levels in IMR-90
The effect of CSC treatment on the abundance of XPC or XPA RNA in IMR-90 cells was mea-
sured using the same doses of CSC that were used to evaluate its effect on protein levels. No sta-
tistically significant changes in the abundance of XPC RNA were observed when cells were
treated with 120 μg/ml or 160 μg/ml CSC, whereas a modest but statistically significant
decrease was observed when cells were treated with 200 μg/ml of CSC (Fig 4). XPA showed
modest, but significant, reduction in RNA expression across all CSC treatments.
CSC inhibits NER and reduces the abundance of XPC protein in BEAS-
2B cells
We also investigated the impact of treatment with CSC on NER in a bronchial epithelial cell
line, BEAS-2B. We chose BEAS-2B cells due to the relevance of epithelial cells as sites of lung
cancer formation, as they are the cells that line the respiratory tract and directly interact with
showing the time course of the effect of CSC on repair of 6–4 PPs in IMR-90 cells. Cells were treated with
200 μg/mL CSC for 8, 16, or 24 h (or DMSO for 24 h) and irradiated with 20 J/m2 UVC to introduce
photolesions. After irradiation, cells were either lysed immediately or after incubation in medium containing
CSC or DMSO for the times shown (3, 6 and 8 h) to permit repair. An immunoblot assay was performed and
samples were loaded in duplicate to measure the removal of 6–4 PPs. (D) A graphical representation of
multiple immunoblots for 6–4 repair is shown. Each data point represents the mean ± SE of three repeats
from one experiment.
doi:10.1371/journal.pone.0158858.g003
Fig 4. The effect of CSC on the abundance of XPC and XPA RNA in IMR-90 cells. Cells were treated with
the indicated concentrations of CSC (or DMSO) for 24 hours. RNA was isolated and Real Time PCR was
performed as described in the methods section. The expression of XPC or XPA RNA was normalized to
GAPDHRNA for each treatment. The data presented are the mean ± SE of one analysis from three
independent experiments.
doi:10.1371/journal.pone.0158858.g004
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inhaled carcinogens. The effect of CSC on cell viability was evaluated by treating cells with the
same dose range chosen for IMR-90 viability (Fig 5A). Some toxicity was observed for BEAS-
2B cells treated with CSC compared to little or no toxicity observed in IMR-90 cells (Fig 1A).
BEAS-2B were actively replicating at the time of treatment, and as a result they were likely
more sensitive than IMR-90 cells to the toxicity of CSC. The effect of CSC on NER was then
studied by measuring the removal of 6-4PPs after treatment with 175 ug/ml CSC for 16 h (Fig
5B). In cells not treated with CSC, NER was rapid and efficient. Treatment with CSC resulted
in significant inhibition of the removal of 6–4 PPs at all three time points (Fig 5C). BEAS-2B
cells were also treated with different doses of CSC for 16 h and probed for XPC and XPA pro-
tein expression (Fig 5D). A reduction in the abundance of XPC protein, but not XPA, was
observed across the range of treatments of BEAS-2B cells with CSC (Fig 5E); similar to our
findings in IMR-90 cells.
The reduction of XPC protein in IMR-90 cells by CSC treatment is
mediated through the proteasome
After observing that treatment of IMR-90 cells with CSC results in a significant reduction in
the abundance of XPC protein, we investigated the potential influence of CSC treatment on
ubiquitin mediated turnover of XPC. UV irradiation induces ubiquitination of XPC protein
[59] and XPC protein abundance has been previously linked to ubiquitin modification. After
UV irradiation, XPC protein levels quickly drop in a proteasome dependent manner [60–62],
although this appears to be both temporary and UV-dose dependent [59]. We also addressed
this by treating IMR-90 cells with MG-132, which permits ubiquitin-linkages but prevents ubi-
quitin-mediated proteasomal degradation, and then exposing those cells to UV irradiation.
XPC levels were reduced after UV exposure, but in the presence of MG-132, this reduction was
significantly diminished (Fig 6A). This confirms that UV-mediated XPC protein levels are
altered in a proteasome-dependent manner. We then asked whether the observed inhibition of
XPC by CSC was also mediated by the proteasome. We treated IMR-90 cells with CSC in the
presence of MG-132 for 16 h and observed that the reduction in XPC protein level produced
by treatment with CSC alone was almost completely abrogated by the addition of MG-132 (Fig
6B). 120 ug/ml CSC reduced XPC expression in the absence of MG-132, but in the presence of
1 and 5 μMMG-132, CSC did not inhibit XPC protein expression, suggesting that the inhibi-
tion of XPC protein expression by CSC requires functional proteasomal activity.
Discussion
In this study, we find that cigarette smoke condensate, a surrogate for tobacco smoke exposure,
can inhibit NER function and reduce the expression of XPC, a key protein required for DNA
damage recognition in the NER pathway. Consequently tobacco smoke exposure can affect the
integrity of DNA in two fundamentally different ways. It is well established that it can intro-
duce DNA damage, an important contributor to lung carcinogenesis. However, our findings
indicate that, in addition, it can also inhibit the DNA repair pathway that is essential for the
removal of some of the carcinogenic DNA damage introduced by smoke carcinogens. Hence,
cells of the lung exposed to smoke would likely suffer an even greater DNA damage burden
than previously held. Certain individual constituents of tobacco smoke have been implicated in
inhibiting DNA repair. Acrolein, a combustion product of cigarette smoke, has been shown to
inhibit the nucleotide excision repair pathway and it inhibits XPC expression in a proteasome-
dependent fashion [63–65]. In addition, arsenic, a metal constituent of tobacco smoke, has
been found to reduce XPC expression [66]. Together, these studies suggest that components of
tobacco smoke can impact lung carcinogenesis by inhibiting NER. CSC can also inhibit the
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Fig 5. CSC inhibits NER and the abundance of XPC protein in BEAS-2B cells. (A) Cells were treated with the concentrations of CSC shown for
16 h and the percentage of viable cells was measured using Trypan blue dye exclusion. The data presented are the mean ± SE of four biological
experiments. (B) Cells were treated with 175 μg/mL CSC (or DMSO) for 16 h, and irradiated with 20 J/m2 UVC to introduce photolesions. After
irradiation, cells were either lysed immediately or after incubation in medium containing CSC or DMSO for increasing periods of time to permit
repair. An immunoblot assay was performed and samples were loaded in duplicate to measure the removal of 6–4 PPs. (C) A graphical
representation of multiple immunoblots for 6–4 repair is shown. Each data point represents the mean ± SE of four repeats from one experiment. (D)
Cells were treated with the different concentrations of CSC shown for 24 h, lysed, and the abundance of XPC and XPA were examined by western
analysis. (E) A graphical representation of multiple western blots for XPC and XPA protein is shown. The data presented are the mean ± SE of two
repeats from two independent experiments for XPC and three repeats of one experiment for XPA. XPC and XPA values were normalized to β-
actin.
doi:10.1371/journal.pone.0158858.g005
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base excision repair (BER) pathway, which repairs oxidative DNA damage, another type of
tobacco smoke damage [43, 44]. Hence, it will be important to investigate how tobacco smoke-
induced alterations in different DNA repair pathways contribute to lung carcinogenesis.
DNA damage recognition is an early, key step in NER and several studies suggest that DNA
damage recognition by XPC is or can be the rate-limiting step in the pathway. Reduced expres-
sion of XPC has been associated with reduced repair of UV-induced photoproducts [67] and
increased cancer incidence [68, 69]. Biochemical and cellular studies indicate that the binding
affinity of XPC for the DNA lesion or the time it takes XPC to find the DNA lesion may be the
specific rate limiting step [70–72]. Conversely, complementation of an XPA deficient cell line
with very low levels of XPA protein fully restores DNA repair activity [73] and XPA becomes
rate limiting only when levels are reduced by over 90% [74, 75]; these studies suggest that the
participation of XPA protein is usually not a rate limiting step in NER. We find that treatment
of cells with CSC inhibits NER and there is a concomitant reduction in XPC protein while
Fig 6. Involvement of the proteasome in the reduced expression of XPC protein in IMR-90 cells after treatment with UV or CSC.
(A) Cells were treated with 10 μMMG-132 or untreated for 4 hours, and then irradiated with 20 J/m2 UV-C. After irradiation, cells were
either lysed immediately or after incubation for increasing periods of time in the same type of medium as was used for the pretreatment;
medium containing MG-132 or not containing MG-132. XPC expression was measured usingWestern blot analysis. (B) A graphical
representation of the experiments from (A) is shown. XPC expression was normalized to β-actin. The data presented are the mean of
two repeats from one experiment. The percent XPC protein was calculated by comparing post-UV time points to the appropriate 0 h
(MG-treated or not MG-treated) time point. Treatment with MG-132 for 4 h had a negligible impact on XPC expression before irradiation,
so both 0 h values were set to 100%. (C) Cells were treated with a combination of CSC and/or MG-132 at the indicated concentrations
for 16 h. XPC levels were measured byWestern blot analysis and normalized to Actin. (D) A graphical representation of the average
obtained from two different blots for the experiments in (C) is shown; treatment with 3 μMMG-132 was not included. XPC expression
was normalized to β-actin.
doi:10.1371/journal.pone.0158858.g006
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XPA protein levels remain unchanged. If XPC protein is rate limiting in NER, then the inhibi-
tion of NER by CSC may be a direct consequence of the reduction in XPC protein. Additional
genetic studies that manipulate the abundance of XPC during or after CSC treatment are
needed to more directly establish the relationship between CSC induced alterations in XPC
protein levels and its inhibition of NER. We find that treatment with CSC results in only a
modest reduction in the levels of XPC RNA and it is only detected well after the amounts of
XPC protein are reduced. This suggests that most of the reduction in XPC protein produced by
treatment with CSC is not caused by a reduction in XPC RNA. Our observation of a reduction
in XPA RNA but not XPA protein after treatment with some concentrations of CSC might be
due to a relatively high abundance of XPA protein or low turnover of the protein. Lastly, an
additional protein, UV DNA Damage Binding Protein 2 (UV-DDB2), is specifically required
for the recognition and removal of CPDs in cells and functions in the turnover of XPC that can
impact the removal of both CPDs and 6-4PPs. We attempted to examine the effect of CSC
treatment on the abundance of DDB2 but were unsuccessful in identifying an antibody that
yielded results specific to the protein.
Previous studies have demonstrated that XPC protein is polyubiquitinated after exposure to
UV light and its polyubiquitination is mediated by the UV-DDB-Ubiquitin ligase complex [59,
61, 76]. There are at least two distinct types of ubiquitin modifications to XPC following UV-
induced DNA damage. A lysine-48-linked polyubiquitin linkage appears to promote degrada-
tion of XPC by the proteasome [77]. In contrast, a lysine-63-linked ubiquitination of XPC can
be critical for the removal of XPC from the lesion site and allow downstream NER factors
access to the DNA damage [78]. In addition, although the type of ubiquitin linkage was not
determined, ubiquitin modification of XPC can actually increase its binding affinity for
undamaged DNA [59] XPC is also modified by sumoylation in response to UV damage [61]
and inhibition of this modification reduces XPC stability after UV irradiation. XPC SUMO
modification has been implicated in promoting lysine-63 mediated XPC polyubiquitination
[78, 79]. A recent report revealed seven unique UV-induced ubiquitination sites on XPC [80].
All of these studies demonstrate the complexity of the post-translational modifications to XPC
in response to DNA damage and they likely represent [81] the intricacies of regulating such an
important and complex pathway.
We observe that treatment with CSC results in a reduction in the abundance of XPC protein
in the absence of UV damage, and that this reduction is reversed when cells are treated with
MG-132. This suggests that the reduction in the abundance of XPC protein produced by expo-
sure to CSC is a consequence of enhanced proteasome-dependent turnover of the protein that
is mediated by ubiquitination. XPC is intrinsically unstable as a monomer [82] and knocking
down one of its binding partners, HR23B, promotes XPC degradation in a proteasome depen-
dent manner [83]. Studies have also found that ubiquitination and proteasome-dependent
turnover of XPC is important in maintaining steady-state levels of the protein in the absence of
DNA damage [84]. In addition, the deubiquitinating enzyme USP-7 removes a UV-induced
polyubiquitin chain from XPC that would otherwise target it for proteasome-mediated degra-
dation [62]. Hence, HR23B and USP-7 both function to stabilize XPC by inhibiting ubiquitin-
mediated degradation. Since treatment with CSC can result in the introduction of different
forms of DNA damage (discussed below), it is possible that the induced turnover of XPC by
the proteasome is mediated through the introduction of certain types of DNA damage. Addi-
tional studies are needed to determine if CSC-mediated turnover of XPC functions by promot-
ing ubiquitination or inhibiting deubiquitination and to characterize the sites of
ubiquitination. CSC has been previously shown to enhance the proteasome-mediated turnover
of Akt, a protein kinase [85], which together with our studies may indicate that smoke exposure
can impact multiple pathways by targeting specific proteins to the proteasome for degradation.
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
PLOS ONE | DOI:10.1371/journal.pone.0158858 July 8, 2016 15 / 22
The assay used to measure NER in this study measures the introduction and removal of UV
light-induced photoproducts. We chose to use this approach because it provides a method to
rapidly introduce DNA damage and it precisely quantitates the kinetics of removal of a model
substrate for the NER pathway. Moreover, the use of UV light as a DNA damaging agent is not
confounded by variations in cellular uptake or metabolic activation as can be the case when
using chemical agents to introduce DNA damage. It is likely that CSC would inhibit the
removal of other substrates for NER but additional studies are required to investigate its effect
on the removal of chemical modifications to DNA introduced by tobacco smoke. Tobacco
smoke contains a number of compounds capable of producing DNA lesions, several of which
are repaired by the NER pathway, including BPDE. The BPDE lesion can be particularly
important in the etiology of smoking-related lung cancer, as the G-T transversion signature
mutation of BPDE [8, 81, 86–88] is found more frequently in at CpG mutational hotspots in
the P53 gene of lung tumors from smokers compared with lung tumors from non-smokers
[89–91]. Mice exposed topically to B[a]P develop skin tumors with the same signature muta-
tions in p53 [92]. Hence, measuring the effect of CSC on the removal of BPDE adducts is
important to directly demonstrate that tobacco smoke exposure inhibits the repair of DNA
damage introduced by the tobacco smoke itself. In our study, it is likely that any adducted base
damage directly introduced by the CSC treatment was very small compared to the levels of
photoproducts introduced by UV irradiation. For example, a previous study found that treat-
ment of rat buccal mucosal cells for 24 h with doses of CSC similar to those used in our study,
introduced approximately 2 DNAmodifications per 1 x 108 bases [93]. Only a subset of this
small number would likely serve as substrates for NER. In contrast, the dose of UV light used
in our studies introduces approximately 5,000 times more adducts than what has been esti-
mated for CSC induced DNA damage and all of these UV-induced lesions are potential sub-
strates for NER [94]. Thus, it is unlikely that the inhibition of NER by CSC treatment was due
to a competition between different types of DNA damage introduced during the experiments
or titration of the NER pathway by damage directly introduced by CSC.
Conclusions
Cigarette smoking remains the highest risk factor for lung cancer development in the United
States and the world. However, not all smokers develop lung cancer. Our results suggest that
CSC, a commonly accepted surrogate for tobacco smoke exposure, inhibits the NER pathway,
increasing the persistence of lesions in DNA. In addition, CSC reduces the abundance of XPC
protein, a key protein required for DNA damage recognition in NER, and this reduction is
likely produced by targeting XPC to the proteasome for degradation. It is well established that
variations in DNA repair capacity contribute to cancer risk, and our findings indicate that inhi-
bition of NER is another mechanism by which smoking may contribute to development of
lung cancer. Therefore, it may be prudent to consider measuring individual DNA repair capac-
ity as a means of evaluating lung cancer risk, particularly among people who have other risk
factors.
Supporting Information
S1 Table. Primers used in quantitative real-time PCR analysis.Multiple primer pairs were
used to measure XPC and XPA RNA expression, and the resulting analysis did not produce
any measurable difference between primer pairs within a single gene, so both primer pairs were
included in the analysis of these genes.
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Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
PLOS ONE | DOI:10.1371/journal.pone.0158858 July 8, 2016 16 / 22
Acknowledgments
We thank the members of our laboratories for helpful discussions
Author Contributions
Conceived and designed the experiments: IM NH CGGMGDKO. Performed the experiments:
NHMG SGH SC. Analyzed the data: IM NHMG. Contributed reagents/materials/analysis
tools: CGG. Wrote the paper: IM NH.
References
1. Islami F, Ward EM, Jacobs EJ, Ma J, Goding Sauer A, Lortet-Tieulent J, et al. Potentially preventable
premature lung cancer deaths in the USA if overall population rates were reduced to those of educated
whites in lower-risk states. Cancer Causes Control. 2015. doi: 10.1007/s10552-014-0517-9 PMID:
25555993.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin.
2011; 61:69–90. doi: 10.3322/caac.20107 PMID: 21296855.
3. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60:277–300. doi: 10.
3322/caac.20073 PMID: 20610543.
4. Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transla-
tional Lung Cancer Research. 2015; 4:327–38. doi: 10.3978/j.issn.2218-6751.2015.08.04 PMID:
26380174; PubMed Central PMCID: PMC4549470.
5. Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends—An
Update. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for
Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016; 25:16–27. doi:
10.1158/1055-9965.EPI-15-0578 PMID: 26667886.
6. Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med. 2011;
32:703–40. doi: 10.1016/j.ccm.2011.08.003 PMID: 22054881; PubMed Central PMCID: PMC3367865.
7. Hecht SS. Lung carcinogenesis by tobacco smoke. International Journal of Cancer. 2012; 131:2724–
32. doi: 10.1002/ijc.27816 PMID: 22945513; PubMed Central PMCID: PMC3479369.
8. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutation
Research. 2004; 567:447–74. doi: 10.1016/j.mrrev.2004.02.001 PMID: 15572290.
9. USDHSS. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon Gen-
eral. Atlanta (GA)2014.
10. Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: geographical dis-
tribution and secular trends. J Thorac Oncol. 2008; 3:819–31. doi: 10.1097/JTO.0b013e31818020eb
PMID: 18670299.
11. Hecht SS. Progress and challenges in selected areas of tobacco carcinogenesis. Chemical Research
in Toxicology. 2008; 21:160–71. doi: 10.1021/tx7002068 PMID: 18052103; PubMed Central PMCID:
PMC2556958.
12. Hecht SS. Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute.
1999; 91:1194–210. PMID: 10413421.
13. Gibbons DL, Byers LA, Kurie JM. Smoking, p53 mutation, and lung cancer. Mol Cancer Res. 2014;
12:3–13. doi: 10.1158/1541-7786.MCR-13-0539 PMID: 24442106; PubMed Central PMCID:
PMC3925633.
14. Talikka M, Sierro N, Ivanov NV, Chaudhary N, Peck MJ, Hoeng J, et al. Genomic impact of cigarette
smoke, with application to three smoking-related diseases. Crit Rev Toxicol. 2012; 42:877–89. doi: 10.
3109/10408444.2012.725244 PMID: 22989067; PubMed Central PMCID: PMC3491444.
15. Gunz D, Hess MT, Naegeli H. Recognition of DNA adducts by human nucleotide excision repair. Evi-
dence for a thermodynamic probing mechanism. The Journal of Biological Chemistry. 1996;
271:25089–98. PMID: 8810263.
16. Hess MT, Gunz D, Luneva N, Geacintov NE, Naegeli H. Base pair conformation-dependent excision of
benzo[a]pyrene diol epoxide-guanine adducts by human nucleotide excision repair enzymes. Molecu-
lar and Cellular Biology. 1997; 17:7069–76. PMID: 9372938; PubMed Central PMCID: PMC232563.
17. Meschini R, Marotta E, Berni A, Filippi S, Fiore M, Mancinelli P, et al. DNA repair deficiency and BPDE-
induced chromosomal alterations in CHO cells. Mutation Research. 2008; 637:93–100. doi: 10.1016/j.
mrfmmm.2007.07.005 PMID: 17720205.
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
PLOS ONE | DOI:10.1371/journal.pone.0158858 July 8, 2016 17 / 22
18. Hang B. Formation and repair of tobacco carcinogen-derived bulky DNA adducts. Journal of Nucleic
Acids. 2010; 2010:709521. doi: 10.4061/2010/709521 PMID: 21234336; PubMed Central PMCID:
PMC3017938.
19. Quan T, States JC. Preferential DNA damage in the p53 gene by benzo[a]pyrene metabolites in cyto-
chrome P4501A1-expressing xeroderma pigmentosum group A cells. Molecular Carcinogenesis.
1996; 16:32–43. doi: 10.1002/(SICI)1098-2744(199605)16:1<32::AID-MC5>3.0.CO;2-Q PMID:
8634092.
20. Quan T, Reiners JJ Jr, Culp SJ, Richter P, States JC. Differential mutagenicity and cytotoxicity of
(+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol and (+/-)-anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-
epoxide in genetically engineered human fibroblasts. Molecular Carcinogenesis. 1995; 12:91–102.
PMID: 7662121.
21. Porter PC, Mellon I, States JC. XP-A cells complemented with Arg228Gln and Val234Leu polymorphic
XPA alleles repair BPDE-induced DNA damage better than cells complemented with the wild type
allele. DNA Repair. 2005; 4:341–9. doi: 10.1016/j.dnarep.2004.10.007 PMID: 15661657.
22. Scharer OD. Nucleotide excision repair in eukaryotes. Cold Spring Harbor Perspectives in Biology.
2013; 5:a012609. doi: 10.1101/cshperspect.a012609 PMID: 24086042; PubMed Central PMCID:
PMC3783044.
23. Smith ML, Seo YR. p53 regulation of DNA excision repair pathways. Mutagenesis. 2002; 17:149–56.
PMID: 11880544.
24. Hwang BJ, Ford JM, Hanawalt PC, Chu G. Expression of the p48 xeroderma pigmentosum gene is
p53-dependent and is involved in global genomic repair. Proceedings of the National Academy of Sci-
ences of the United States of America. 1999; 96:424–8. PMID: 9892649; PubMed Central PMCID:
PMC15152.
25. Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum
group C gene. Proceedings of the National Academy of Sciences of the United States of America.
2002; 99:12985–90. doi: 10.1073/pnas.202485699 PMID: 12242345; PubMed Central PMCID:
PMC130573.
26. Barckhausen C, RoosWP, Naumann SC, Kaina B. Malignant melanoma cells acquire resistance to
DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-medi-
ated DNA repair. Oncogene. 2014; 33:1964–74. doi: 10.1038/onc.2013.141 PMID: 23604128.
27. Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, et al. Xeroderma pigmentosum
group C protein complex is the initiator of global genome nucleotide excision repair. Molecular Cell.
1998; 2:223–32. PMID: 9734359.
28. VermeulenW, Fousteri M. Mammalian transcription-coupled excision repair. Cold Spring Harbor Per-
spectives in Biology. 2013; 5:a012625. doi: 10.1101/cshperspect.a012625 PMID: 23906714; PubMed
Central PMCID: PMC3721277.
29. Coggins CR. A further review of inhalation studies with cigarette smoke and lung cancer in experimen-
tal animals, including transgenic mice. Inhal Toxicol. 2010; 22:974–83. doi: 10.3109/08958378.2010.
501831 PMID: 20698816.
30. Hecht SS. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new. Carci-
nogenesis. 2005; 26:1488–92. doi: 10.1093/carcin/bgi148 PMID: 15930027.
31. Hutt JA, Vuillemenot BR, Barr EB, Grimes MJ, Hahn FF, Hobbs CH, et al. Life-span inhalation exposure
to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic
pathways. Carcinogenesis. 2005; 26:1999–2009. doi: 10.1093/carcin/bgi150 PMID: 15944214.
32. Witschi H. Tobacco smoke-induced lung cancer in animals—a challenge to toxicology (?). International
Journal of Toxicology. 2007; 26:339–44. doi: 10.1080/10915810701490380 PMID: 17661225.
33. Balansky R, Ganchev G, Iltcheva M, Steele VE, De Flora S. Prevention of cigarette smoke-induced
lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine. International Jour-
nal of Cancer. 2010; 126:1047–54. doi: 10.1002/ijc.24942 PMID: 19816928.
34. Kwon MC, Berns A. Mouse models for lung cancer. Mol Oncol. 2013; 7:165–77. doi: 10.1016/j.molonc.
2013.02.010 PMID: 23481268.
35. Chen G, Gingerich J, Soper L, Douglas GR, White PA. Induction of lacZ mutations in MutaMouse pri-
mary hepatocytes. Environmental and Molecular Mutagenesis. 2010; 51:330–7. doi: 10.1002/em.
20540 PMID: 19953605; PubMed Central PMCID: PMC2959491.
36. DeMarini DM, Gudi R, Szkudlinska A, Rao M, Recio L, Kehl M, et al. Genotoxicity of 10 cigarette smoke
condensates in four test systems: comparisons between assays and condensates. Mutation Research.
2008; 650:15–29. doi: 10.1016/j.mrgentox.2007.09.006 PMID: 18006367.
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
PLOS ONE | DOI:10.1371/journal.pone.0158858 July 8, 2016 18 / 22
37. Guo X, Verkler TL, Chen Y, Richter PA, Polzin GM, Moore MM, et al. Mutagenicity of 11 cigarette
smoke condensates in two versions of the mouse lymphoma assay. Mutagenesis. 2011; 26:273–81.
doi: 10.1093/mutage/geq083 PMID: 20980367.
38. Hsu TC, Cherry LM, Bucana C, Shirley LR, Gairola CG. Mitosis-arresting effects of cigarette smoke
condensate on human lymphoid cell lines. Mutation Research. 1991; 259:67–78. PMID: 1988824.
39. Luo LZ, Werner KM, Gollin SM, SaundersWS. Cigarette smoke induces anaphase bridges and geno-
mic imbalances in normal cells. Mutation Research. 2004; 554:375–85. doi: 10.1016/j.mrfmmm.2004.
06.031 PMID: 15450433.
40. Moktar A, Ravoori S, VadhanamMV, Gairola CG, Gupta RC. Cigarette smoke-induced DNA damage
and repair detected by the comet assay in HPV-transformed cervical cells. International Journal of
Oncology. 2009; 35:1297–304. PMID: 19885552; PubMed Central PMCID: PMC2896024.
41. Foresta M, Izzotti A, La Maestra S, Micale R, Poggi A, Vecchio D, et al. Accelerated repair and reduced
mutagenicity of DNA damage induced by cigarette smoke in human bronchial cells transfected with E.
coli formamidopyrimidine DNA glycosylase. PloS One. 2014; 9:e87984. doi: 10.1371/journal.pone.
0087984 PMID: 24498234; PubMed Central PMCID: PMC3909288.
42. Jaiswal AS, Panda H, Pampo CA, Siemann DW, Gairola CG, Hromas R, et al. Adenomatous polyposis
coli-mediated accumulation of abasic DNA lesions lead to cigarette smoke condensate-induced neo-
plastic transformation of normal breast epithelial cells. Neoplasia. 2013; 15:454–60. PMID: 23555190;
PubMed Central PMCID: PMC3612917.
43. Moktar A, Singh R, VadhanamMV, Ravoori S, Lillard JW, Gairola CG, et al. Cigarette smoke conden-
sate-induced oxidative DNA damage and its removal in human cervical cancer cells. International Jour-
nal of Oncology. 2011; 39:941–7. doi: 10.3892/ijo.2011.1106 PMID: 21720711; PubMed Central
PMCID: PMC3760590.
44. Kundu CN, Balusu R, Jaiswal AS, Gairola CG, Narayan S. Cigarette smoke condensate-induced level
of adenomatous polyposis coli blocks long-patch base excision repair in breast epithelial cells. Onco-
gene. 2007; 26:1428–38. doi: 10.1038/sj.onc.1209925 PMID: 16924228.
45. Narayan S, Jaiswal AS, Kang D, Srivastava P, Das GM, Gairola CG. Cigarette smoke condensate-
induced transformation of normal human breast epithelial cells in vitro. Oncogene. 2004; 23:5880–9.
doi: 10.1038/sj.onc.1207792 PMID: 15208684.
46. Han SG, Pant K, Bruce SW, Gairola CG. Bhas 42 cell transformation activity of cigarette smoke con-
densate is modulated by selenium and arsenic. Environmental and Molecular Mutagenesis. 2016. doi:
10.1002/em.22000 PMID: 26924598.
47. Curtin GM, Hanausek M, Walaszek Z, Mosberg AT, Slaga TJ. Short-term in vitro and in vivo analyses
for assessing the tumor-promoting potentials of cigarette smoke condensates. Toxicological Sciences:
an official journal of the Society of Toxicology. 2004; 81:14–25. doi: 10.1093/toxsci/kfh172 PMID:
15159522.
48. Gairola C. Genetic effects of fresh cigarette smoke in Saccharomyces cerevisiae. Mutation Research.
1982; 102:123–36. PMID: 6755230.
49. Walaszek Z, Hanausek M, Slaga TJ. The role of skin painting in predicting lung cancer. International
Journal of Toxicology. 2007; 26:345–51. doi: 10.1080/10915810701490422 PMID: 17661226.
50. Friedberg EC, Bond JP, Burns DK, Cheo DL, Greenblatt MS, Meira LB, et al. Defective nucleotide exci-
sion repair in xpc mutant mice and its association with cancer predisposition. Mutation Research. 2000;
459:99–108. PMID: 10725660.
51. Ide F, Iida N, Nakatsuru Y, Oda H, Tanaka K, Ishikawa T. Mice deficient in the nucleotide excision repair
gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors. Carcinogenesis. 2000;
21:1263–5. PMID: 10837020.
52. Ishikawa T, Ide F, Qin X, Zhang S, Takahashi Y, Sekiguchi M, et al. Importance of DNA repair in carci-
nogenesis: evidence from transgenic and gene targeting studies. Mutation Research. 2001; 477:41–9.
PMID: 11376685.
53. Hollander MC, Philburn RT, Patterson AD, Velasco-Miguel S, Friedberg EC, Linnoila RI, et al. Deletion
of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis.
Proceedings of the National Academy of Sciences of the United States of America. 2005; 102:13200–
5. doi: 10.1073/pnas.0503133102 PMID: 16141330; PubMed Central PMCID: PMC1201581.
54. Pillsbury HC, Bright CC. Comparison of aliquot and complete sample procedure for the determination
of nicotine in cigarette smoke. Journal—Association of Official Analytical Chemists. 1972; 55:636–8.
PMID: 5044748.
55. Ford JM, Hanawalt PC. Expression of wild-type p53 is required for efficient global genomic nucleotide
excision repair in UV-irradiated human fibroblasts. J Biol Chem. 1997; 272:28073–80. PMID: 9346961.
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
PLOS ONE | DOI:10.1371/journal.pone.0158858 July 8, 2016 19 / 22
56. Mellon I, Hock T, Reid R, Porter PC, States JC. Polymorphisms in the human xeroderma pigmentosum
group A gene and their impact on cell survival and nucleotide excision repair. DNA Repair (Amst).
2002; 1:531–46. PMID: 12509227.
57. Wang YC, Maher VM, Mitchell DL, McCormick JJ. Evidence frommutation spectra that the UV hyper-
mutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a tem-
plate containing photoproducts. Molecular and Cellular Biology. 1993; 13:4276–83. PMID: 8321229;
PubMed Central PMCID: PMC359977.
58. Moser J, Volker M, Kool H, Alekseev S, Vrieling H, Yasui A, et al. The UV-damaged DNA binding pro-
tein mediates efficient targeting of the nucleotide excision repair complex to UV-induced photo lesions.
DNA Repair. 2005; 4:571–82. doi: 10.1016/j.dnarep.2005.01.001 PMID: 15811629.
59. Sugasawa K, Okuda Y, Saijo M, Nishi R, Matsuda N, Chu G, et al. UV-induced ubiquitylation of XPC
protein mediated by UV-DDB-ubiquitin ligase complex. Cell. 2005; 121:387–400. doi: 10.1016/j.cell.
2005.02.035 PMID: 15882621.
60. Wang QE, Praetorius-Ibba M, Zhu Q, El-Mahdy MA, Wani G, Zhao Q, et al. Ubiquitylation-independent
degradation of Xeroderma pigmentosum group C protein is required for efficient nucleotide excision
repair. Nucleic Acids Research. 2007; 35:5338–50. doi: 10.1093/nar/gkm550 PMID: 17693435;
PubMed Central PMCID: PMC2018625.
61. Wang QE, Zhu Q, Wani G, El-Mahdy MA, Li J, Wani AA. DNA repair factor XPC is modified by SUMO-1
and ubiquitin following UV irradiation. Nucleic Acids Research. 2005; 33:4023–34. doi: 10.1093/nar/
gki684 PMID: 16030353; PubMed Central PMCID: PMC1178000.
62. He J, Zhu Q, Wani G, Sharma N, Han C, Qian J, et al. Ubiquitin-specific protease 7 regulates nucleotide
excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing
ultraviolet light-induced and VCP/p97 protein-regulated proteolysis. The Journal of Biological Chemis-
try. 2014; 289:27278–89. doi: 10.1074/jbc.M114.589812 PMID: 25118285; PubMed Central PMCID:
PMC4175359.
63. Wang HT, Hu Y, Tong D, Huang J, Gu L, Wu XR, et al. Effect of carcinogenic acrolein on DNA repair
and mutagenic susceptibility. The Journal of Biological Chemistry. 2012; 287:12379–86. doi: 10.1074/
jbc.M111.329623 PMID: 22275365; PubMed Central PMCID: PMC3320987.
64. Tang MS, Wang HT, Hu Y, ChenWS, Akao M, Feng Z, et al. Acrolein induced DNA damage, mutage-
nicity and effect on DNA repair. Molecular Nutrition & Food Research. 2011; 55:1291–300. doi: 10.
1002/mnfr.201100148 PMID: 21714128; PubMed Central PMCID: PMC4606864.
65. Feng Z, HuW, Hu Y, Tang MS. Acrolein is a major cigarette-related lung cancer agent: Preferential
binding at p53 mutational hotspots and inhibition of DNA repair. Proceedings of the National Academy
of Sciences of the United States of America. 2006; 103:15404–9. doi: 10.1073/pnas.0607031103
PMID: 17030796; PubMed Central PMCID: PMC1592536.
66. Nollen M, Ebert F, Moser J, Mullenders LH, Hartwig A, Schwerdtle T. Impact of arsenic on nucleotide
excision repair: XPC function, protein level, and gene expression. Molecular Nutrition & Food
Research. 2009; 53:572–82. doi: 10.1002/mnfr.200800480 PMID: 19382146.
67. Renaud E, Miccoli L, Zacal N, Biard DS, Craescu CT, Rainbow AJ, et al. Differential contribution of
XPC, RAD23A, RAD23B and CENTRIN 2 to the UV-response in human cells. DNA Repair. 2011;
10:835–47. doi: 10.1016/j.dnarep.2011.05.003 PMID: 21676658.
68. Yang M, Kang MJ, Choi Y, Kim CS, Lee SM, Park CW, et al. Associations between XPC expression,
genotype, and the risk of head and neck cancer. Environmental and Molecular Mutagenesis. 2005;
45:374–9. doi: 10.1002/em.20097 PMID: 15657918.
69. Qiu J, Wang X, Meng X, Zheng Y, Li G, Ma J, et al. Attenuated NER expressions of XPF and XPC asso-
ciated with smoking are involved in the recurrence of bladder cancer. PloS One. 2014; 9:e115224. doi:
10.1371/journal.pone.0115224 PMID: 25535740; PubMed Central PMCID: PMC4275238.
70. Yeo JE, Khoo A, Fagbemi AF, Scharer OD. The efficiencies of damage recognition and excision corre-
late with duplex destabilization induced by acetylaminofluorene adducts in human nucleotide excision
repair. Chemical Research in Toxicology. 2012; 25:2462–8. doi: 10.1021/tx3003033 PMID: 23088760;
PubMed Central PMCID: PMC3502718.
71. Luijsterburg MS, von Bornstaedt G, Gourdin AM, Politi AZ, Mone MJ, Warmerdam DO, et al. Stochastic
and reversible assembly of a multiprotein DNA repair complex ensures accurate target site recognition
and efficient repair. The Journal of Cell Biology. 2010; 189:445–63. doi: 10.1083/jcb.200909175 PMID:
20439997; PubMed Central PMCID: PMC2867314.
72. Nishi R, Alekseev S, Dinant C, Hoogstraten D, Houtsmuller AB, Hoeijmakers JH, et al. UV-DDB-depen-
dent regulation of nucleotide excision repair kinetics in living cells. DNA Repair. 2009; 8:767–76. doi:
10.1016/j.dnarep.2009.02.004 PMID: 19332393.
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
PLOS ONE | DOI:10.1371/journal.pone.0158858 July 8, 2016 20 / 22
73. Muotri AR, Marchetto MC, Suzuki MF, Okazaki K, Lotfi CF, Brumatti G, et al. Low amounts of the DNA
repair XPA protein are sufficient to recover UV-resistance. Carcinogenesis. 2002; 23:1039–46. PMID:
12082027.
74. Koberle B, Roginskaya V, Wood RD. XPA protein as a limiting factor for nucleotide excision repair and
UV sensitivity in human cells. DNA Repair. 2006; 5:641–8. doi: 10.1016/j.dnarep.2005.12.001 PMID:
16413230.
75. Kang TH, Reardon JT, Sancar A. Regulation of nucleotide excision repair activity by transcriptional and
post-transcriptional control of the XPA protein. Nucleic Acids Research. 2011; 39:3176–87. doi: 10.
1093/nar/gkq1318 PMID: 21193487; PubMed Central PMCID: PMC3082913.
76. Matsumoto S, Fischer ES, Yasuda T, Dohmae N, Iwai S, Mori T, et al. Functional regulation of the DNA
damage-recognition factor DDB2 by ubiquitination and interaction with xeroderma pigmentosum group
C protein. Nucleic Acids Research. 2015; 43:1700–13. doi: 10.1093/nar/gkv038 PMID: 25628365;
PubMed Central PMCID: PMC4330392.
77. Puumalainen MR, Lessel D, Ruthemann P, Kaczmarek N, Bachmann K, Ramadan K, et al. Chromatin
retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity.
Nature Communications. 2014; 5:3695. doi: 10.1038/ncomms4695 PMID: 24770583; PubMed Central
PMCID: PMC4007632.
78. van Cuijk L, van Belle GJ, Turkyilmaz Y, Poulsen SL, Janssens RC, Theil AF, et al. SUMO and ubiqui-
tin-dependent XPC exchange drives nucleotide excision repair. Nature Communications. 2015;
6:7499. doi: 10.1038/ncomms8499 PMID: 26151477; PubMed Central PMCID: PMC4501428.
79. Poulsen SL, Hansen RK, Wagner SA, van Cuijk L, van Belle GJ, Streicher W, et al. RNF111/Arkadia is
a SUMO-targeted ubiquitin ligase that facilitates the DNA damage response. The Journal of Cell Biol-
ogy. 2013; 201:797–807. doi: 10.1083/jcb.201212075 PMID: 23751493; PubMed Central PMCID:
PMC3678163.
80. Povlsen LK, Beli P, Wagner SA, Poulsen SL, Sylvestersen KB, Poulsen JW, et al. Systems-wide analy-
sis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.
Nature Cell Biology. 2012; 14:1089–98. doi: 10.1038/ncb2579 PMID: 23000965.
81. Yoon JH, Smith LE, Feng Z, Tang M, Lee CS, Pfeifer GP. Methylated CpG dinucleotides are the prefer-
ential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian
cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer
Research. 2001; 61:7110–7. PMID: 11585742.
82. Bunick CG, Miller MR, Fuller BE, Fanning E, Chazin WJ. Biochemical and structural domain analysis of
xeroderma pigmentosum complementation group C protein. Biochemistry. 2006; 45:14965–79. doi: 10.
1021/bi061370o PMID: 17154534; PubMed Central PMCID: PMC2579963.
83. Ng JM, VermeulenW, van der Horst GT, Bergink S, Sugasawa K, Vrieling H, et al. A novel regulation
mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pig-
mentosum group C protein. Genes & Development. 2003; 17:1630–45. doi: 10.1101/gad.260003
PMID: 12815074; PubMed Central PMCID: PMC196135.
84. Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, et al. A proteome-wide, quantitative sur-
vey of in vivo ubiquitylation sites reveals widespread regulatory roles. Molecular & Cellular Proteomics:
MCP. 2011; 10:M111. doi: 10.1074/mcp.M111.013284 PMID: 21890473; PubMed Central PMCID:
PMC3205876.
85. Kim SY, Lee JH, Huh JW, Ro JY, Oh YM, Lee SD, et al. Cigarette smoke induces Akt protein degrada-
tion by the ubiquitin-proteasome system. The Journal of Biological Chemistry. 2011; 286:31932–43.
doi: 10.1074/jbc.M111.267633 PMID: 21778238; PubMed Central PMCID: PMC3173210.
86. Eisenstadt E, Warren AJ, Porter J, Atkins D, Miller JH. Carcinogenic epoxides of benzo[a]pyrene and
cyclopenta[cd]pyrene induce base substitutions via specific transversions. Proc Natl Acad Sci U S A.
1982; 79:1945–9. PMID: 7043469; PubMed Central PMCID: PMC346098.
87. Zhao B, Wang J, Geacintov NE, Wang Z. Poleta, Polzeta and Rev1 together are required for G to T
transversion mutations induced by the (+)- and (-)-trans-anti-BPDE-N2-dG DNA adducts in yeast cells.
Nucleic Acids Research. 2006; 34:417–25. doi: 10.1093/nar/gkj446 PMID: 16415180; PubMed Central
PMCID: PMC1331986.
88. Nik-Zainal S, Kucab JE, Morganella S, Glodzik D, Alexandrov LB, Arlt VM, et al. The genome as a
record of environmental exposure. Mutagenesis. 2015; 30:763–70. doi: 10.1093/mutage/gev073
PMID: 26443852; PubMed Central PMCID: PMC4637815.
89. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene:
clues to cancer etiology and molecular pathogenesis. Cancer Research. 1994; 54:4855–78. PMID:
8069852.
90. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung
cancer mutational hotspots in P53. Science. 1996; 274:430–2. PMID: 8832894.
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
PLOS ONE | DOI:10.1371/journal.pone.0158858 July 8, 2016 21 / 22
91. Hainaut P, Pfeifer GP. Patterns of p53 G—>T transversions in lung cancers reflect the primary muta-
genic signature of DNA-damage by tobacco smoke. Carcinogenesis. 2001; 22:367–74. PMID:
11238174.
92. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJ. Benzo[a]pyrene-induced
murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proceedings of
the National Academy of Sciences of the United States of America. 1993; 90:1013–7. PMID: 8430068;
PubMed Central PMCID: PMC45801.
93. Autrup JL, Hansen C, Autrup H. Detection of tobacco smoke carcinogen-DNA adducts in cultured rat
buccal mucosa cells following exposure to ethanol and total cigarette smoke condensate or chewing
tobacco. Chemico-Biological Interactions. 1992; 85:141–50. PMID: 1493606.
94. Mellon I, Bohr VA, Smith CA, Hanawalt PC. Preferential DNA repair of an active gene in human cells.
Proceedings of the National Academy of Sciences of the United States of America. 1986; 83:8878–82.
PMID: 3466163; PubMed Central PMCID: PMC387036.
Cigarette Smoke Condensate Inhibits Nucleotide Excision Repair
PLOS ONE | DOI:10.1371/journal.pone.0158858 July 8, 2016 22 / 22
